OASIS Clinical Study
Cryosa has received Investigational Device Exemption (IDE) status to initiate the OASIS
clinical study for patients with moderate to severe obstructive sleep apnea who cannot
benefit from or tolerate traditional treatments.
The Cryosa System uses a minimally invasive approach to remove tissue from the
airway that limits breathing while sleeping. Rather than removing the tissue surgically,
the system uses precisely controlled cooling, a well-established process known as
adipose cryolysis, to selectively target the offending tissue while preserving surrounding
tissue. In a single procedure, the Cryosa System treats both the tongue base and soft
palate to help maintain an open airway during sleep.
More details on OASIS can be found on the Clinical Trials website.
Previous Studies
Cryosa has completed a pilot study to demonstrate to assess the safety and
performance of the Cryosa procedure. Additionally, Cryosa has conducted pre-clinical
research to support procedural safety and demonstrate that meaningful fat reduction
may be achieved with the Cryosa approach.